Insights
Search Results
Client Highlights
2.26.26
Wilson Sonsini Advises Eventus on Majority Investment by Terminus Capital Partners
On February 26, 2026, Terminus Capital Partners (TCP), a growth‑oriented private equity firm focused on majority investments in B2B software companies, and Eventus, a leading provider of comprehensive, at-scale trade surveillance and financial risk solutions, announced that TCP has acquired majority control in Eventus, positioning the firm for accelerated geographical expansion and growth in its product offerings. Wilson Sonsini Goodrich & Rosati advised Eventus on the transaction.
Client Highlights
2.12.26
Wilson Sonsini Advises Delta40 on $20 Million Funding
On February 11, 2026, Delta40, an integrated venture studio and VC fund investing in and supporting founders on the frontlines of Africa’s most urgent challenges, announced $20 million in funding. The milestone marks Africa’s first institutional raise linking venture building and early-stage capital, merging investment with hands-on studio support from experienced operators to build and scale start-ups across the continent. Wilson Sonsini Goodrich & Rosati advised Delta40 on the transaction.
Delta40 initially launched its venture studio model in Kenya and has since expanded to Lagos, Nigeria, providing portfolio companies with direct, on-the-ground support as they scale across the continent. Delta40 pioneered a unique venture studio and fund model that combines early-stage capital with embedded product, fundraising, commercial, finance, legal, growth, and exit expertise. Through this model, Delta40 partners with founders from idea to scale across energy and mobility, agriculture, and fintech—with a goal to integrate AI across all sectors.
Delta40 initially launched its venture studio model in Kenya and has since expanded to Lagos, Nigeria, providing portfolio companies with direct, on-the-ground support as they scale across the continent. Delta40 pioneered a unique venture studio and fund model that combines early-stage capital with embedded product, fundraising, commercial, finance, legal, growth, and exit expertise. Through this model, Delta40 partners with founders from idea to scale across energy and mobility, agriculture, and fintech—with a goal to integrate AI across all sectors.
Client Highlights
8.28.25
Firm Advises SparkMeter on Platform Acquisition by Honeywell
On August 20, 2025, Honeywell announced the expansion of its Smart Energy portfolio with the tuck-in acquisition of three utility platforms from SparkMeter, Inc., a provider of leading grid management solutions for utilities. The acquisition includes intellectual property and certain related assets from SparkMeter. Wilson Sonsini Goodrich & Rosati advised SparkMeter on the transaction.
Client Highlights
4.11.25
Wilson Sonsini Advises Parallel Systems on $38 Million Series B
On April 11, 2025, Los Angeles-based Parallel Systems, an autonomous-railcar company, announced that it successfully completed a $38 million Series B financing round led by Anthos Capital with participation from Collaborative Fund, Congruent Ventures, and Riot Ventures, among others. Wilson Sonsini Goodrich & Rosati advised Parallel Systems on the transaction.
Client Highlights
1.27.23
Wilson Sonsini Advises Alleviant Medical on $75 Million Financing
On January 26, 2023, Alleviant Medical, Inc., a privately-held medical device company developing a no-implant interatrial shunt for heart failure, announced the closing of a $75 million equity financing co-led by S3 Ventures and RiverVest Venture Partners. The lead investors in this new funding round are joined by Vensana Capital, Longview Ventures, TMC Venture Fund, and a strategic investor, in addition to Gilmartin Capital, ShangBay Capital, and another undisclosed strategic investor. This financing will fund the company’s global pivotal trial, ALLAY-HF (Safety and Efficacy of the Alleviant System for No-Implant Interatrial Shunt Creation in Patients with Chronic Heart Failure). ALLAY-HF is designed to demonstrate the safety and effectiveness of the Alleviant System for the treatment of heart failure through left atrial decompression. Wilson Sonsini Goodrich & Rosati represented Alleviant Medical in the transaction.
Client Highlights
8.24.21
Wilson Sonsini Advises Siemens Financial Services on 80 Acres Farms' $160 Million Series B
On August 9, 2021, 80 Acres Farms, an industry-leading vertical farming company, announced it secured $160 million in additional funding in a round led by General Atlantic and joined by Siemens Financial Services, Inc. (the U.S. financing arm of global technology company Siemens). The funding round also included Blue Earth (formerly PG Impact Investments) and General Atlantic's Beyond Net Zero team, in addition to participation from existing investors including Barclays and Taurus. The company intends to utilize the capital for continued expansion and product development, building from its current footprint of vertical farms that yield a diverse offering of high-quality produce. Wilson Sonsini Goodrich & Rosati represented Siemens Financial Services in the transaction.
News Articles
10.05.20
Wilson Sonsini Contributes to Groundbreaking Racial Justice Infractions Report “Cited for Being in Plain Sight”
The Lawyers Committee for Civil Rights of the San Francisco Bay Area recently published a groundbreaking report—Cited for Being in Plain Sight—examining racial disparities in enforcement of alleged infractions against Black, Latinx, and unhoused Californians simply for sitting, sleeping, and standing in public. The report reveals that the disparate charging of such infractions does nothing to help the people affected by them, but rather burdens them with typically uncollectible debt that only serves to push them deeper into the shadows of society.
Client Highlights
6.10.20
Wilson Sonsini Advises National Instruments in Acquisition of OptimalPlus
On June 2, 2020, National Instruments Corporation, a provider of automated test equipment and virtual instrumentation software, announced it had entered into a definitive agreement to acquire Israeli data analytics company OptimalPlus Ltd. Wilson Sonsini Goodrich & Rosati is advising National Instruments in the transaction.